Mood Disorders clinical trials at UCLA
1 research study open to eligible people
Mobile-enhanced Group CBT for Adolescents at Risk Severe Mood Disorders
open to eligible people ages 13-17
Although cognitive-behavioral therapy (CBT) has shown efficacy in reducing symptoms and rates of mood relapse in adolescents at high risk for severe mood disorders (SMD; i.e., bipolar I/II disorder and recurrent or unremitting major depression), a significant limitation to the CBT's efficacy is the low rate of participant adherence to the prescribed between-session homework tasks. Mobile health applications have the potential to improve adherence to and acceptance of treatment through embedded treatment content, skill-practice, thought and symptom monitoring, all of which are facilitated by reward contingencies and notifications. This study examines whether a mobile application-enhanced CBT can improve participant adherence and treatment acceptance for adolescents at high risk for SMD.
Los Angeles, California
Our lead scientists for Mood Disorders research studies include Marc J. Weintraub, PhD.
Last updated: